[go: up one dir, main page]

Ramnath et al., 2018 - Google Patents

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

Ramnath et al., 2018

View HTML
Document ID
2179296306673841399
Author
Ramnath D
Irvine K
Lukowski S
Horsfall L
Loh Z
Clouston A
Patel P
Fagan K
Iyer A
Lampe G
Stow J
Schroder K
Fairlie D
Powell J
Powell E
Sweet M
Publication year
Publication venue
JCI insight

External Links

Snippet

Chronic liver disease (CLD) is associated with tissue-destructive fibrosis. Considering that common mechanisms drive fibrosis across etiologies, and that steatosis is an important cofactor for pathology, we performed RNA sequencing on liver biopsies of patients with …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Similar Documents

Publication Publication Date Title
Ramnath et al. Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes
Yang et al. A novel circular RNA mediates pyroptosis of diabetic cardiomyopathy by functioning as a competing endogenous RNA
Kumar et al. Circulating miRNA biomarkers for Alzheimer's disease
Liu et al. LncRNA‐TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism
Li et al. Integrated miRNA-Seq and mRNA-Seq study to identify miRNAs associated with Alzheimer’s disease using post-mortem brain tissue samples
Zhou et al. miR-185 inhibits fibrogenic activation of hepatic stellate cells and prevents liver fibrosis
Lu et al. Identification of blood circular RNAs as potential biomarkers for acute ischemic stroke
Zhang et al. LncRNA FLVCR1‐AS1 acts as miR‐513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma
Blauensteiner et al. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients
Wang et al. MiR-223-3p alleviates vascular endothelial injury by targeting IL6ST in Kawasaki disease
Benz et al. Circulating MicroRNA‐223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
Yang et al. Overexpression of miR-223 tips the balance of pro-and anti-hypertrophic signaling cascades toward physiologic cardiac hypertrophy
Lu et al. Elevated serum miR‐7, miR‐9, miR‐122, and miR‐141 are noninvasive biomarkers of acute pancreatitis
Wang et al. HDAC1-mediated deacetylation of HIF1α prevents atherosclerosis progression by promoting miR-224-3p-mediated inhibition of FOSL2
Bao et al. Up‐regulation of circular RNA hsa_circ_0037909 promotes essential hypertension
Cui et al. miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
Yang et al. mmu_circ_0000790 is involved in pulmonary vascular remodeling in mice with HPH via microRNA-374c-mediated FOXC1
Yin et al. Circular RNAs in diabetes and its complications: Current knowledge and future prospects
Han et al. Identification of biomarkers in nonalcoholic fatty liver disease: a machine learning method and experimental study
Tian et al. The Clinical Significance of Changes in the Expression Levels of MicroRNA‐1 and Inflammatory Factors in the Peripheral Blood of Children with Acute‐Stage Asthma
Han et al. Lipopolysaccharide alters the m6A epitranscriptomic tagging of RNAs in cardiac tissue
Tacke et al. miR‐155 predicts long‐term mortality in critically ill patients younger than 65 years
Li et al. Inflammatory-miR-301a circuitry drives mTOR and Stat3-dependent PSC activation in chronic pancreatitis and PanIN
Hu et al. Impact of chronic intermittent hypoxia on the long non‐coding RNA and mRNA expression profiles in myocardial infarction
Yuan et al. Circular RNA expression in the lungs of a mouse model of sepsis induced by cecal ligation and puncture